OnKure Funding & Investors
OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer.
onkuretherapeutics.comTotal Amount Raised: $121,493,872
OnKure Funding Rounds
Series C
$54,000,000
Series C Investors
Surveyor CapitalAcorn BioventuresCormorant Asset ManagementPerceptive AdvisorsDeep Track CapitalSamsara BiocapitalBlackRockSeries B
$56,649,181
Series B Investors
Acorn BioventuresCormorant Asset ManagementPerceptive AdvisorsSamsara BiocapitalSurveyor CapitalDebt Financing
$2,000,000
Series A
$7,000,000
Series A Investors
Beijing Delian InvestmentOnKure managementSeed
$495,000
Seed
$599,705
Grant
$250,000
Pre Seed
$499,985
Funding info provided by Diffbot.